Adverse Effects of Angiotensin-Converting Enzyme Inhibitors in Humans: A Systematic Review and Meta-Analysis of 378 Randomized Controlled Trials.

Mingkwan Na TakuathungWannachai SakuludomkanRapheephorn KhatsriNahathai DukaewNapatsorn KraivisitkulBalqis AhmadmusaChollada MahakkanukrauhKachathip WangthaweesapJirakit OninSalin SrichaiNida BuawangpongNut Koonrungsesomboon

Published in: International journal of environmental research and public health (2022)

We quantified the relative risk of numerous adverse events associated with the use of ACE inhibitors in a variety of demographics. This information can help healthcare providers be fully informed about any potential adverse consequences and make appropriate suggestions for their patients requiring ACE inhibitor therapy.

Keyphrases

angiotensin converting enzyme
angiotensin ii
healthcare
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
stem cells
health information
emergency department
patient reported outcomes
mesenchymal stem cells
health insurance
patient reported